Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela D Filiou

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Proteomics. Clinical Applications|January 27, 2015
Can proteomics-based diagnostics aid clinical psychiatry?Michaela D Filiou
Methods in Molecular Biology (Clifton, N.J.)|March 31, 2015
Protein profiling and phosphoprotein analysis by isoelectric focusingGiuseppina Maccarrone, Michaela D Filiou
Trends in Neurosciences|August 1, 2019
Anxiety and Brain Mitochondria: A Bidirectional CrosstalkMichaela D Filiou, Carmen Sandi
Methods in Molecular Biology (Clifton, N.J.)|January 11, 2012
Psychiatric disorder biomarker discovery using quantitative proteomicsMichaela D Filiou, Christoph W Turck
International Review of Neurobiology|November 5, 2011
General overview: biomarkers in neuroscience researchMichaela D Filiou, Christoph W Turck
Neuroscience and Biobehavioral Reviews|August 1, 2024
Mitochondrial dynamics and psychiatric disorders: The missing linkMaria P Papageorgiou, Michaela D Filiou
Molecular Neuropsychiatry|September 8, 2016
What Have Mass Spectrometry-Based Proteomics and Metabolomics (Not) Taught Us about Psychiatric Disorders?Christoph W Turck, Michaela D Filiou
Methods in Molecular Biology (Clifton, N.J.)|November 30, 2016
Using <sup>15</sup>N-Metabolic Labeling for Quantitative Proteomic AnalysesGiuseppina Maccarrone, Alon Chen, Michaela D Filiou
CNS & Neurological Disorders Drug Targets|October 7, 2017
The 18-kDa Translocator Protein as a CNS Drug Target: Finding Our Way Through the Neuroinflammation FogMichaela D Filiou, Richard B Banati, Manuel B Graeber
Proteomics. Clinical Applications|February 1, 2011
Quantitative proteomics for investigating psychiatric disordersMichaela D Filiou, Christoph W Turck, Daniel Martins-de-Souza
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Proteomics. Clinical Applications|January 27, 2015
Can proteomics-based diagnostics aid clinical psychiatry?Michaela D Filiou
Methods in Molecular Biology (Clifton, N.J.)|March 31, 2015
Protein profiling and phosphoprotein analysis by isoelectric focusingGiuseppina Maccarrone, Michaela D Filiou
Trends in Neurosciences|August 1, 2019
Anxiety and Brain Mitochondria: A Bidirectional CrosstalkMichaela D Filiou, Carmen Sandi
Methods in Molecular Biology (Clifton, N.J.)|January 11, 2012
Psychiatric disorder biomarker discovery using quantitative proteomicsMichaela D Filiou, Christoph W Turck
International Review of Neurobiology|November 5, 2011
General overview: biomarkers in neuroscience researchMichaela D Filiou, Christoph W Turck
Neuroscience and Biobehavioral Reviews|August 1, 2024
Mitochondrial dynamics and psychiatric disorders: The missing linkMaria P Papageorgiou, Michaela D Filiou
Molecular Neuropsychiatry|September 8, 2016
What Have Mass Spectrometry-Based Proteomics and Metabolomics (Not) Taught Us about Psychiatric Disorders?Christoph W Turck, Michaela D Filiou
Methods in Molecular Biology (Clifton, N.J.)|November 30, 2016
Using <sup>15</sup>N-Metabolic Labeling for Quantitative Proteomic AnalysesGiuseppina Maccarrone, Alon Chen, Michaela D Filiou
CNS & Neurological Disorders Drug Targets|October 7, 2017
The 18-kDa Translocator Protein as a CNS Drug Target: Finding Our Way Through the Neuroinflammation FogMichaela D Filiou, Richard B Banati, Manuel B Graeber
Proteomics. Clinical Applications|February 1, 2011
Quantitative proteomics for investigating psychiatric disordersMichaela D Filiou, Christoph W Turck, Daniel Martins-de-Souza
Pageof 6